Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

CELZ Creative Medical Technology Holdings Inc

6,45

0,00 (0,00%)

Avant marché

Dernière mise à jour : 12:11:44

Retardé de 15 minutes

Form S-1 - General form for registration of securities under the Securities Act of 1933

nullnullnullnullnull

Creative Medical Technol... (NASDAQ:CELZ)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025

Plus de graphiques de la Bourse Creative Medical Technol...

Creative Medical Technol... (NASDAQ:CELZ)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025

Plus de graphiques de la Bourse Creative Medical Technol...

Actualités Creative Medical Technology Holdings Inc

Form 4 - Statement of changes in beneficial ownership of securities
Vendredi 21 Février 2025 ( il y a 2 semaines) • Edgar (US Regulatory)

Creative Medical Technology Holdings Applauds Presidential Initiative to Expand IVF Access, Showcasing OvaStem® Program's Success and Growth Potential
Jeudi 20 Février 2025 ( il y a 2 semaines) • GlobeNewswire Inc.

Creative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing StemSpine® Procedure using AlloStem™
Vendredi 14 Février 2025 ( il y a 3 semaines) • GlobeNewswire Inc.

Creative Medical Technology Reports Positive One-Year Results for AlloStem™ Type 2 Diabetes Program
Mardi 11 Février 2025 ( il y a 3 semaines) • GlobeNewswire Inc.

Creative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz Pipeline Development
Mercredi 5 Février 2025 ( il y a 4 semaines) • GlobeNewswire Inc.

Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain
Jeudi 30 Janvier 2025 ( il y a 1 mois) • GlobeNewswire Inc.

Form 8-K - Current report
Jeudi 26 Décembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Mercredi 20 Novembre 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Mercredi 20 Novembre 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent Review, Validating the Safety and Potential of CELZ-201 for Chronic Lower Back Pain Treatment
Mercredi 13 Novembre 2024 ( il y a 4 mois) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Vendredi 8 Novembre 2024 ( il y a 4 mois) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Vendredi 8 Novembre 2024 ( il y a 4 mois) • Edgar (US Regulatory)

Plus d'articles sur Creative Medical Technology Holdings Inc

Societe Generale

Lvmh Moet Hennessy Louis...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales